Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
01 Feb 2022, 16:37:37 UTC
Prior SEC filing
15 Sep 2021
Next SEC filing
23 Feb 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Birgit Girshick

Key filing fact

Birgit Girshick filed Form 4 for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) on 01 Feb 2022.

Key facts

  • This page summarizes Birgit Girshick's Form 4 filing for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 01 Feb 2022, 16:37.

Change

  • Previous filing in this sequence was filed on 15 Sep 2021.
  • Current net transaction value: -$1,210,554.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRL transaction

Common Stock

Gift

Transaction value
$0
Shares
-531
Change %
-1.9%
Price
$0.000000
Shares after
27,071
Date
23 Sep 2021
Ownership
Direct
CRL transaction

Common Stock

Award

Transaction value
$0
Shares
+11,029
Change %
+41%
Price
$0.000000
Shares after
38,100
Date
28 Jan 2022
Ownership
Direct
Footnotes
F1
CRL transaction

Common Stock

Tax liability

Transaction value
$1,210,554
Shares
-3,877
Change %
-10%
Price
$312.24
Shares after
34,223
Date
28 Jan 2022
Ownership
Direct
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on February 22, 2019.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .